SM

Sivala Murali

Director Director DIN 07557596
DIN 07557596 First appointment Jun 2016 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2016
Shareholding value Locked Premium profile

About Sivala Murali

Data last updated:

Sivala Murali has 10 years in corporate governance. Formerly with 1 company, such as Honey Drugs And Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07557596
Primary Designation Director
First Appointment 27 Jun 2016
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director27 Jun 20162015Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Honey Drugs And Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sivala Murali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivala Murali

Sivala Murali has 10 years in corporate governance. Formerly with 1 company, such as Honey Drugs And Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Sivala Murali is associated with 0 companies as a director.

Sivala Murali has expertise in General Business.

Sivala Murali has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available